Articles

Surgeons should take greater precaution when compiling patient safety incidence (PSI) reports for cataract surgical care.

The One Use-Plus SBK, the new generation of LASIK microkeratomes, achieves accuracy and visual results equivalent to femtolasers at a fraction of the cost.

Oculus will be presenting its new Corvis ST device at the ESCRS exhibition in Vienna this year.

A study published in the British Journal of Ophthalmology has defined the heterogenous nature of retinal disorders.

During this year?s ESCRS in Vienna CROMA will highlight its history of 35 years as a key player in ophthalmology.

Rasagiline can be used as a systematic treatment to improve chances of retinal ganglion cell (RGC) survival in glaucomatous eyes

Exercise can reduce intraocular pressure (IOP), ocular pulse amplitude (OPA) and axial length (AXL).

The GDx Staging System is an efficient way to interpret retinal fibre layer (RNFL) damage.

The natural immunity to allogeneic corneal tissue is stronger in allergic conjunctivitis and is linked to lymphatic ingrowth.

Corneas in microphthalmic eyes have significantly higher central corneal thickness (CCT) regardless of whether or not the patient underwent congenital cataract surgery.

According to data recently published, trypan blue (TB) doesn't cause injury to the retinal pigment epithelium (RPE) when used in vitreoretinal surgery...

A recent study has shown that there is a negative correlation between the horizontal corneal diameter (HCD) and the central corneal thickness (CCT) in microphthalmic eyes irrespective of previous congential cataract surgery...

Draining the aqueous humour from the anterior chamber to the suprachoroidal space using a suprachoroidal silicone tube shunt implant is an effective way to lower intraocular pressure (IOP), according to a recent study.

After the recent launch of CROMA's EYE-Cee One hydrophobic one-piece aspheric intraocular lens (IOL) with blue light filter, we spoke with Dr Jean-Michel Bosc on his experiences and opinions of this new product...

Advanced Retinal Therapy will be held in Vienna, Austria on 3 December 2011. At this event updates, trends and controversies in retinal tehrapy will be discussed in symposia, key-note lectures and a panel discussion session.

The National Institute for Health and Clinical Excellence (NICE) has recommended Ozurdex for the treatment of macular oedema caused by central retinal vein occlusion (CRVO).

Anticoagulation (warafin) therapy was linked to a higher risk of post vitreoretinal surgery (VRS) bleeding in comparison with antipletelet (aspirin, clopidogrel) therapy vitreoretinal.

Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients.

Data presented in an advance on-line publication of the journal Eye has shown a high occurrence of ocular conditions in UK leprosy patients.

Romania has opened the Europe Eye Hospital in Bucharest this month. This private eye hospital is reportedly the largest in south-eastern Europe and will mean Romanians won't have to travel far for cataract treatments and other surgical procedures.

Occurrence of, a significantly increased area of capillary nonperfusion is significantly low in eyes with branch retinal vein occlusion (BRVO) after administration of intravitreal bevacizumab (IVB),

Operator-dependent centring and automatic centring retinal nerve fibre layer (RNFL) thickness measurement patterns (RNFL3.45 and NHM4) have been shown to be in good agreement.

A non-steroidal anti-inflammatory drug (NSAID), for the treatment of postoperative ocular inflammation following cataract extraction, has been approved for use in the European market by the European Commission.

Macular inner retinal layer (mIRL) is linked to visual sensitivity in glaucoma patients

After a corneal collagen cross-linking (CXL) procedure a patient's cornea thins but then recovers towards original thickness.

Ever-widening knowledge base proves that there's more to it than controlling IOPs.

Baerveldt device showed better outcomes but required more interventions then Ahmed valve.

Anti-vascular endothelial growth factor agent well-tolerated, met primary efficacy endpoint.

For compromised, and potentially compromised eyes.

FDA results and personal experience demonstrate very high satisfaction with lens